Figure 2. BAF subunit mutations in human neurologic diseases indicate dosage-sensitive roles in human neural development.

Dosage sensitivity is likely to reflect a rate limiting step in neural development and may help explain why recapitulating the microRNA-chromatin switch can reprogram human fibroblasts to neurons. Missense mutations in BAF subunits also imply gain-of-function or dominant-negative effects in neurologic diseases.